AKT1 and glioma: Additionally, in gliomas, epigenetic reprogramming of the PI3K/AKT/mTOR signaling axis drives a metabolic shift from oxidative phosphorylation to aerobic glycolysis, and this metabolic reprogramming serves as a core hub for regulating the secretory factor network in the immune microenvironment (66).